US Stock MarketDetailed Quotes

ENZN ENZON PHARMACEUTICALS INC

Watchlist
  • 0.150000
  • -0.006300-4.03%
15min DelayClose Sep 6 16:00 ET
11.13MMarket Cap30.00P/E (TTM)

ENZON PHARMACEUTICALS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
0.21%46.23M
0.24%45.99M
0.06%47.01M
0.06%47.01M
-0.63%46.56M
-1.42%46.13M
-3.27%45.88M
-1.38%46.98M
-1.38%46.98M
-2.17%46.85M
-Cash and cash equivalents
0.21%46.23M
0.24%45.99M
0.06%47.01M
0.06%47.01M
-0.63%46.56M
-1.42%46.13M
-3.27%45.88M
-1.38%46.98M
-1.38%46.98M
-2.17%46.85M
Receivables
----
----
----
----
----
----
----
----
----
--0
Other current assets
15.54%409K
26.58%481K
-18.27%331K
-18.27%331K
-18.77%329K
-17.67%354K
826.83%380K
376.47%405K
376.47%405K
462.50%405K
Total current assets
0.33%46.64M
0.46%46.47M
-0.09%47.34M
-0.09%47.34M
-0.79%46.89M
-1.56%46.49M
-2.56%46.26M
-0.77%47.39M
-0.77%47.39M
-1.47%47.26M
Non current assets
Non current deferred assets
90.37%356K
51.26%360K
77.72%359K
77.72%359K
--111K
--187K
--238K
--202K
--202K
----
Total non current assets
90.37%356K
51.26%360K
77.72%359K
77.72%359K
--111K
--187K
--238K
--202K
--202K
--0
Total assets
0.69%46.99M
0.72%46.83M
0.24%47.7M
0.24%47.7M
-0.55%47M
-1.17%46.67M
-2.05%46.5M
-0.35%47.59M
-0.35%47.59M
-1.47%47.26M
Liabilities
Current liabilities
Payables
0.00%331K
0.00%331K
0.00%1.61M
0.00%1.61M
1.81%337K
0.00%331K
0.00%331K
385.20%1.61M
385.20%1.61M
0.00%331K
-accounts payable
0.00%331K
0.00%331K
0.00%331K
0.00%331K
1.81%337K
0.00%331K
0.00%331K
0.00%331K
0.00%331K
0.00%331K
-Dividends payable
--0
--0
0.00%1.28M
0.00%1.28M
--0
--0
--0
--1.28M
--1.28M
----
Current accrued expenses
-16.90%59K
146.75%190K
5.75%92K
5.75%92K
-26.60%69K
54.35%71K
-2.53%77K
42.62%87K
42.62%87K
104.35%94K
Other current liabilities
--20K
----
166.67%16K
166.67%16K
----
----
----
-45.45%6K
-45.45%6K
----
Current liabilities
1.99%410K
27.70%521K
0.88%1.71M
0.88%1.71M
-4.47%406K
6.63%402K
-0.49%408K
321.59%1.7M
321.59%1.7M
12.73%425K
Non current liabilities
Preferred securities outside stock equity
0.00%43.55M
0.00%43.01M
0.00%42.48M
0.00%42.48M
0.00%44.08M
0.00%43.55M
0.00%43.01M
0.00%42.48M
0.00%42.48M
5.00%44.08M
Total non current liabilities
0.00%43.55M
0.00%43.01M
0.00%42.48M
0.00%42.48M
0.00%44.08M
0.00%43.55M
0.00%43.01M
0.00%42.48M
0.00%42.48M
5.00%44.08M
Total liabilities
0.02%43.96M
0.26%43.54M
0.03%44.2M
0.03%44.2M
-0.04%44.48M
0.06%43.95M
-0.00%43.42M
3.02%44.18M
3.02%44.18M
5.07%44.5M
Shareholders'equity
Share capital
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
-common stock
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
0.00%742K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
----
----
--0
Retained earnings
2.22%-70.07M
2.08%-70.35M
1.91%-70.67M
1.91%-70.67M
1.43%-71.34M
0.96%-71.66M
0.42%-71.85M
-0.26%-72.04M
-0.26%-72.04M
-1.05%-72.38M
Paid-in capital
-1.73%72.37M
-1.72%72.9M
-1.71%73.43M
-1.71%73.43M
-1.71%73.12M
-1.70%73.65M
-1.69%74.18M
-1.68%74.71M
-1.68%74.71M
-2.74%74.39M
Total stockholders'equity
11.52%3.04M
7.19%3.29M
2.88%3.51M
2.88%3.51M
-8.74%2.52M
-17.47%2.73M
-24.05%3.07M
-30.01%3.41M
-30.01%3.41M
-50.86%2.76M
Total equity
11.52%3.04M
7.19%3.29M
2.88%3.51M
2.88%3.51M
-8.74%2.52M
-17.47%2.73M
-24.05%3.07M
-30.01%3.41M
-30.01%3.41M
-50.86%2.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 0.21%46.23M0.24%45.99M0.06%47.01M0.06%47.01M-0.63%46.56M-1.42%46.13M-3.27%45.88M-1.38%46.98M-1.38%46.98M-2.17%46.85M
-Cash and cash equivalents 0.21%46.23M0.24%45.99M0.06%47.01M0.06%47.01M-0.63%46.56M-1.42%46.13M-3.27%45.88M-1.38%46.98M-1.38%46.98M-2.17%46.85M
Receivables --------------------------------------0
Other current assets 15.54%409K26.58%481K-18.27%331K-18.27%331K-18.77%329K-17.67%354K826.83%380K376.47%405K376.47%405K462.50%405K
Total current assets 0.33%46.64M0.46%46.47M-0.09%47.34M-0.09%47.34M-0.79%46.89M-1.56%46.49M-2.56%46.26M-0.77%47.39M-0.77%47.39M-1.47%47.26M
Non current assets
Non current deferred assets 90.37%356K51.26%360K77.72%359K77.72%359K--111K--187K--238K--202K--202K----
Total non current assets 90.37%356K51.26%360K77.72%359K77.72%359K--111K--187K--238K--202K--202K--0
Total assets 0.69%46.99M0.72%46.83M0.24%47.7M0.24%47.7M-0.55%47M-1.17%46.67M-2.05%46.5M-0.35%47.59M-0.35%47.59M-1.47%47.26M
Liabilities
Current liabilities
Payables 0.00%331K0.00%331K0.00%1.61M0.00%1.61M1.81%337K0.00%331K0.00%331K385.20%1.61M385.20%1.61M0.00%331K
-accounts payable 0.00%331K0.00%331K0.00%331K0.00%331K1.81%337K0.00%331K0.00%331K0.00%331K0.00%331K0.00%331K
-Dividends payable --0--00.00%1.28M0.00%1.28M--0--0--0--1.28M--1.28M----
Current accrued expenses -16.90%59K146.75%190K5.75%92K5.75%92K-26.60%69K54.35%71K-2.53%77K42.62%87K42.62%87K104.35%94K
Other current liabilities --20K----166.67%16K166.67%16K-------------45.45%6K-45.45%6K----
Current liabilities 1.99%410K27.70%521K0.88%1.71M0.88%1.71M-4.47%406K6.63%402K-0.49%408K321.59%1.7M321.59%1.7M12.73%425K
Non current liabilities
Preferred securities outside stock equity 0.00%43.55M0.00%43.01M0.00%42.48M0.00%42.48M0.00%44.08M0.00%43.55M0.00%43.01M0.00%42.48M0.00%42.48M5.00%44.08M
Total non current liabilities 0.00%43.55M0.00%43.01M0.00%42.48M0.00%42.48M0.00%44.08M0.00%43.55M0.00%43.01M0.00%42.48M0.00%42.48M5.00%44.08M
Total liabilities 0.02%43.96M0.26%43.54M0.03%44.2M0.03%44.2M-0.04%44.48M0.06%43.95M-0.00%43.42M3.02%44.18M3.02%44.18M5.07%44.5M
Shareholders'equity
Share capital 0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K
-common stock 0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K0.00%742K
-Preferred stock --0--0--0--0--0--0--0----------0
Retained earnings 2.22%-70.07M2.08%-70.35M1.91%-70.67M1.91%-70.67M1.43%-71.34M0.96%-71.66M0.42%-71.85M-0.26%-72.04M-0.26%-72.04M-1.05%-72.38M
Paid-in capital -1.73%72.37M-1.72%72.9M-1.71%73.43M-1.71%73.43M-1.71%73.12M-1.70%73.65M-1.69%74.18M-1.68%74.71M-1.68%74.71M-2.74%74.39M
Total stockholders'equity 11.52%3.04M7.19%3.29M2.88%3.51M2.88%3.51M-8.74%2.52M-17.47%2.73M-24.05%3.07M-30.01%3.41M-30.01%3.41M-50.86%2.76M
Total equity 11.52%3.04M7.19%3.29M2.88%3.51M2.88%3.51M-8.74%2.52M-17.47%2.73M-24.05%3.07M-30.01%3.41M-30.01%3.41M-50.86%2.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg